bpc-157 nitric oxide – Vascular Repair & Enhancer BPC-157 Rapid Release - InfiniWell

Subcutaneous administration achieves similar bioavailability while avoiding deeper tissue penetration

WADA lists BPC-157 as prohibited at all times for governed athletes in the S0-Non-Approved Substance category

Standard titration protocol The typical titration mirrors the general semaglutide dosing approach but with oral-specific adjustments: Phase 1 (Weeks 1 through 4): Start with the 2 mg/0.1 mg tablet once daily

The skin pinch is especially important for people with lower body fat percentages, those using needles longer than 6mm, and anyone injecting in the thigh or upper arm where subcutaneous fat tends to be thinner than in the abdomen